Ixico PLC | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
46.78 M |
Public Float |
- |
Ixico PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.04 |
Market Cap |
GBP13.8 M |
Shares Outstanding |
46.78 M |
Public Float |
27.68 M |
Address |
Griffin Court London Greater London EC1A 9PN United Kingdom |
Employees | - |
Website | http://ixico.com/ |
Updated | 07/08/2019 |
IXICO Plc engages in the provision of technology-enabled specialty services to the global biopharmaceutical industry. Its services are used to select patients for clinical trials, assess the safety and efficacy of new drugs in development, and in post marketing surveillance. The company was founded by Derek Lionel Glendon Hill on November 28, 1995 and is headquartered in London, the United Kingdom. |